Basal-complex n(%) | 17q12 n(%) | Luminal-complex n(%) | Luminal-simple n(%) | Amplifier n(%) | Mixed n(%) | |
---|---|---|---|---|---|---|
Group size | 67 | 51 | 105 | 46 | 52 | 38 |
Hereditary status | ||||||
BRCA1-mutated | 17 (25) | 0 | 1 (1) | 0 | 2 (4) | 2 (5) |
BRCA2-mutated | 5 (7) | 1 (2) | 25 (24) | 0 | 0 | 1 (3) |
Familial | 15 (22) | 19 (37) | 38 (36) | 23 (50) | 29 (56) | 8 (21) |
Sporadic | 30 (45) | 31 (61) | 41 (39) | 23 (50) | 21 (40) | 27 (71) |
Clinical parameters | ||||||
ER+ | 7 (10) | 19 (37) | 91 (87) | 44 (96) | 40 (77) | 26 (68) |
ER- | 56 (84) | 29 (57) | 11 (10) | 2 (4) | 10 (19) | 11 (29) |
LN+ | 19 (28) | 25 (49) | 42 (40) | 12 (26) | 20 (38) | 19 (50) |
LN- | 43 (64) | 19 (37) | 50 (48) | 32 (70) | 28 (54) | 18 (47) |
Mean tumor size (mm ± SD) | 27 ± 12 | 31 ± 21 | 26 ± 17 | 21 ± 10 | 25 ± 13 | 25 ± 11 |
Histologic grade 1 | 1 (1) | 1 (2) | 5 (5) | 9 (20) | 8 (15) | 2 (5) |
Histologic grade 2 | 5 (7) | 14 (27) | 31 (30) | 21 (46) | 19 (37) | 10 (26) |
Histologic grade 3 | 42 (63) | 19 (37) | 26 (25) | 4 (9) | 9 (17) | 6 (16) |
Molecular subtypes by Hu et al. [4] | ||||||
Basal-like | 56 (84) | 5 (10) | 4 (4) | 0 | 8 (15) | 6 (16) |
HER2-enriched | 0 | 30 (59) | 3 (3) | 0 | 0 | 1 (3) |
Luminal B | 1 (1) | 3 (6) | 48 (46) | 1 (2) | 12 (23) | 5 (13) |
Luminal A | 1 (1) | 6 (12) | 31 (30) | 33 (72) | 12 (23) | 12 (32) |
Normal-like | 3 (4) | 6 (12) | 3 (3) | 6 (13) | 10 (19) | 6 (16) |
Unclassified | 6 (9) | 1 (2) | 16 (15) | 6 (13) | 10 (19) | 8 (21) |
FGA (mean %) | ||||||
Overall FGA (%) | 53 | 26 | 37 | 19 | 31 | 29 |
Gain FGA (%) | 18 | 12 | 15 | 9 | 15 | 12 |
Loss FGA (%) | 34 | 14 | 22 | 10 | 16 | 18 |